Compounds > cloxyquin

cloxyquin and 8-hydroxy-2-methylquinoline

cloxyquin has been researched along with 8-hydroxy-2-methylquinoline in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT1
Byrd, MS; Campos, CG; Clare, M; Cotter, PA; Hagen, TJ; Henderson, MW; Horn, JR; Masoudi, A; Myler, PJ; Wangtrakuldee, P; Zhang, Z1
Aoki, S; Ariyasu, S; Hanaya, K; Hoshi, M; Morita, A; Sawa, A; Takahashi, I; Wang, B1
Aoki, S; Ariyasu, S; Hanaya, K; Shoji, M; Sugai, T; Yoshioka, S1
Campbell, Y; Cardellina, JH; Eccard, VS; Ensel, SM; Guernieri, R; Harrell, WA; Montgomery, V; Roxas-Duncan, V; Smith, LA; Vieira, RC; Webb, RP1
Abendroth, J; Audia, JP; Chen, C; Edwards, TE; Hagen, TJ; Helgren, TR; Horn, JR; Housley, NA; Myler, PJ; Sankaran, B; Staker, BL; Wangtrakuldee, P1
Brunst, S; Burgers, LD; Frank, D; Fürst, R; Gobec, S; Martinelli, G; Proschak, A; Proschak, E; Rotter, MJ; Sosič, I; Weizel, L; Wichelhaus, TA1

Other Studies

7 other study(ies) available for cloxyquin and 8-hydroxy-2-methylquinoline

ArticleYear
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
    Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2

    Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc

2011
Discovery of Inhibitors of
    ACS medicinal chemistry letters, 2013, Jul-01, Volume: 4, Issue:8

    Topics:

2013
Design and synthesis of 8-hydroxyquinoline-based radioprotective agents.
    Bioorganic & medicinal chemistry, 2014, Aug-01, Volume: 22, Issue:15

    Topics: Apoptosis; Cell Line, Tumor; Drug Design; Electrophoretic Mobility Shift Assay; Gamma Rays; Humans; Oxyquinoline; Radiation-Protective Agents; Tumor Suppressor Protein p53; Zinc

2014
Development of a novel sulfonate ester-based prodrug strategy.
    Bioorganic & medicinal chemistry letters, 2016, Jan-15, Volume: 26, Issue:2

    Topics: Aeromonas; Alkanesulfonates; Aminopeptidases; Animals; Chloroquinolinols; Cyclization; Humans; Hydrolysis; Leucine; Liver; Mice; Prodrugs; Propylamines; Rats; Sulfonamides

2016
A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: Animals; Binding Sites; Botulinum Toxins, Type A; Hydroxyquinolines; Inhibitory Concentration 50; Mice; Phrenic Nerve; Protein Binding; Serogroup; Structure-Activity Relationship

2017
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
    Bioorganic & medicinal chemistry, 2017, 02-01, Volume: 25, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Methionyl Aminopeptidases; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Pulmonary Artery; Rats; Rickettsia prowazekii; Structure-Activity Relationship

2017
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
    European journal of medicinal chemistry, 2022, Jan-15, Volume: 228

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship

2022